ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,104Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 1571

$1.48M Total Retail Price of All Prescriptions

Rank: 26 out of 1571

595 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 595 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 7,586 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$163 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 608 518 1 6
METFORMIN HCL 574 498 2 9
JANUVIA 327 273 3 50
SIMVASTATIN 325 282 4 1
ZETIA 265 248 5 73
ACTOS 234 184 6 92
ALLOPURINOL 229 209 7 36
LISINOPRIL 187 155 8 5
LOVASTATIN 184 162 9 33
LANTUS 178 109 10 65
AMLODIPINE BESYLATE 177 163 11 2
NIASPAN 170 135 12 130
DIOVAN 149 118 13 19
LOSARTAN POTASSIUM 145 143 14 17
ATORVASTATIN CALCIUM 143 114 15 8
GLYBURIDE 143 118 R 15 99
INSULIN SYRINGE 140 83 17 124
VYTORIN 139 109 18 224
SYNTHROID 138 127 19 59
PEN NEEDLE 134 93 20 128
BENAZEPRIL HCL 132 127 21 32
HUMALOG 127 70 22 150
PIOGLITAZONE HCL 126 103 R 23 274
CRESTOR 122 92 24 25
CARVEDILOL 118 92 25 10
VICTOZA 3-PAK 116 97 26 314
BYETTA 111 87 27 407
PRAVASTATIN SODIUM 111 101 27 26
LOVAZA 107 72 29 90
METOPROLOL SUCCINATE 105 90 30 16
LANTUS SOLOSTAR 102 84 31 149
ALENDRONATE SODIUM 99 92 32 22
VITAMIN D2 86 68 33 552
FENOFIBRATE 82 52 34 129
HYDROCHLOROTHIAZIDE 80 76 35 18
GLIPIZIDE 79 68 36 53
FUROSEMIDE 75 61 37 7
METOPROLOL TARTRATE 74 71 38 13
LOSARTAN-HYDROCHLOROTHIAZIDE 70 69 39 77
DIOVAN HCT 69 66 40 64
GLIMEPIRIDE 65 48 41 70
JANUMET 63 63 42 200
TAMSULOSIN HCL 57 57 43 11
TRILIPIX 54 38 44 268
METFORMIN HCL ER 53 46 45 108
ONGLYZA 52 45 46 265
BYDUREON 52 48 46 449
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.